AERI insider filings

AERIE PHARMACEUTICALS INC — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-11-21. Screen AERI transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for AERI between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — AERIE PHARMACEUTICALS INC

FiledFormInsiderReported transactionsSource
2022-11-214McHugh Julie — DirectorDisposition to issuer (D): 16,095 @ $15.25 · Disposition to issuer (D): 7,800 (derivative) @ $1.98 · Disposition to issuer (D): 16,854 (derivative) @ $9.14EDGAR
2022-11-214McDonnell Peter J — DirectorDisposition to issuer (D): 7,995 @ $15.25 · Disposition to issuer (D): 16,854 (derivative) @ $9.14EDGAR
2022-11-214Kopczynski Casey C. — Chief Scientific OfficerDisposition to issuer (D): 280,244 @ $15.25 · Disposition to issuer (D): 25,000 (derivative) @ $12.10 · Disposition to issuer (D): 65,941 (derivative) @ $6.45EDGAR
2022-11-214Lang Peter Frederick — Chief Financial OfficerDisposition to issuer (D): 46,297 @ $15.25 · Disposition to issuer (D): 160,551 (derivative) @ $6.45EDGAR
2022-11-214LaRocca John — General CounselDisposition to issuer (D): 53,585 @ $15.25 · Disposition to issuer (D): 65,941 (derivative) @ $6.45EDGAR
2022-11-214du Toit Michael — DirectorDisposition to issuer (D): 16,095 @ $15.25 · Disposition to issuer (D): 7,800 (derivative) @ $1.98 · Disposition to issuer (D): 16,854 (derivative) @ $9.14EDGAR
2022-11-214Croarkin Richard — DirectorDisposition to issuer (D): 16,095 @ $15.25 · Disposition to issuer (D): 25,000 (derivative) @ $4.81 · Disposition to issuer (D): 7,800 (derivative) @ $1.98 · Disposition to issuer (D): 16,854 (derivative) @ $9.14EDGAR
2022-11-214Calabrese Jeffrey — Vice President of FinanceDisposition to issuer (D): 18,585 @ $15.25 · Disposition to issuer (D): 6,257 (derivative) @ $4.23 · Disposition to issuer (D): 20,774 (derivative) @ $6.89EDGAR
2022-11-214KANNAN RAJ — Chief Executive Officer, DirectorDisposition to issuer (D): 215,783 @ $15.25 · Disposition to issuer (D): 387,169 (derivative) @ $7.14 · Disposition to issuer (D): 197,239 (derivative) @ $6.45EDGAR
2022-11-214MCGRAW BENJAMIN F III — DirectorDisposition to issuer (D): 41,984 @ $15.25 · Disposition to issuer (D): 7,800 (derivative) @ $1.98 · Disposition to issuer (D): 102,412 (derivative) @ $3.66 · Disposition to issuer (D): 16,854 (derivative) @ $9.14EDGAR
2022-11-214GRYSKA DAVID W — DirectorDisposition to issuer (D): 11,495 @ $15.25 · Disposition to issuer (D): 1,996 @ $15.25 · Disposition to issuer (D): 7,800 (derivative) @ $1.98 · Disposition to issuer (D): 16,854 (derivative) @ $9.14EDGAR
2022-11-034Calabrese Jeffrey — Vice President of FinanceTax withholding (F): 179 @ $15.22EDGAR
2022-08-164LaRocca John — General CounselTax withholding (F): 771 @ $11.57EDGAR
2022-08-164Calabrese Jeffrey — Vice President of FinanceTax withholding (F): 265 @ $11.57EDGAR
2022-07-134Calabrese Jeffrey — Vice President of FinanceTax withholding (F): 266 @ $8.36EDGAR
2022-07-064Calabrese Jeffrey — Vice President of FinanceGrant/award (A): 11,276 @ $0 · Grant/award (A): 20,774 (derivative) @ $0EDGAR
2022-06-134McHugh Julie — DirectorGrant/award (A): 6,245 @ $0 · Grant/award (A): 16,854 (derivative) @ $0EDGAR
2022-06-134McDonnell Peter J — DirectorGrant/award (A): 6,245 @ $0 · Grant/award (A): 16,854 (derivative) @ $0EDGAR
2022-06-134du Toit Michael — DirectorGrant/award (A): 6,245 @ $0 · Grant/award (A): 16,854 (derivative) @ $0EDGAR
2022-06-134Croarkin Richard — DirectorGrant/award (A): 6,245 @ $0 · Grant/award (A): 16,854 (derivative) @ $0EDGAR
2022-06-134MCGRAW BENJAMIN F III — DirectorGrant/award (A): 6,245 @ $0 · Grant/award (A): 16,854 (derivative) @ $0EDGAR
2022-06-134GRYSKA DAVID W — DirectorGrant/award (A): 6,245 @ $0 · Grant/award (A): 16,854 (derivative) @ $0EDGAR
2022-03-224Kopczynski Casey C. — Chief Scientific OfficerGrant/award (A): 19,015 @ $0 · Grant/award (A): 65,941 (derivative) @ $0EDGAR
2022-03-224LaRocca John — General CounselGrant/award (A): 19,015 @ $0 · Grant/award (A): 65,941 (derivative) @ $0EDGAR
2022-03-224KANNAN RAJ — Chief Executive Officer, DirectorGrant/award (A): 197,239 (derivative) @ $0EDGAR
2022-03-224Lang Peter Frederick — Chief Financial OfficerGrant/award (A): 46,297 @ $0 · Grant/award (A): 160,551 (derivative) @ $0EDGAR
2022-03-024MCGRAW BENJAMIN F III — Interim Executive Chair, DirectorTax withholding (F): 10,324 @ $8.30EDGAR
2022-02-234LaRocca John — General CounselTax withholding (F): 1,973 @ $6EDGAR
2022-02-094Kopczynski Casey C. — Chief Scientific OfficerTax withholding (F): 701 @ $7.24 · Tax withholding (F): 700 @ $7.33EDGAR
2022-02-094LaRocca John — General CounselTax withholding (F): 768 @ $7.24EDGAR
2022-02-094MITRO THOMAS A — President and COOTax withholding (F): 1,310 @ $7.24 · Tax withholding (F): 1,111 @ $7.33EDGAR
2022-02-084Hollander David — Chief R&D OfficerTax withholding (F): 927 @ $7.05EDGAR
2022-02-084Kopczynski Casey C. — Chief Scientific OfficerTax withholding (F): 963 @ $7.05 · Tax withholding (F): 876 @ $7.05EDGAR
2022-02-084LaRocca John — General CounselTax withholding (F): 1,206 @ $7.05 · Tax withholding (F): 384 @ $7.05EDGAR
2022-02-084MITRO THOMAS A — President and COOTax withholding (F): 1,435 @ $7.05 · Tax withholding (F): 1,435 @ $7.05EDGAR
2022-02-014MCGINLEY KATHLEEN — CHRO & VP, Corp ServicesTax withholding (F): 878 @ $6.92EDGAR
2021-12-224KANNAN RAJ — Chief Executive Officer, DirectorGrant/award (A): 215,783 @ $0 · Grant/award (A): 387,169 (derivative) @ $0EDGAR
2021-11-154Hollander David — Chief R&D OfficerTax withholding (F): 2,162 @ $12.06EDGAR
2021-09-224MCGRAW BENJAMIN F III — Interim Executive Chair, DirectorGrant/award (A): 34,513 @ $0 · Grant/award (A): 102,412 (derivative) @ $0EDGAR
2021-08-174LaRocca John — General CounselTax withholding (F): 765 @ $14.70EDGAR
2021-08-174Staten Christopher — Interim CFOTax withholding (F): 877 @ $14.70EDGAR
2021-06-214McHugh Julie — DirectorGrant/award (A): 1,750 @ $0 · Grant/award (A): 7,800 (derivative) @ $0EDGAR
2021-06-214du Toit Michael — DirectorGrant/award (A): 1,750 @ $0 · Grant/award (A): 7,800 (derivative) @ $0EDGAR
2021-06-214Cagle Gerald D. — DirectorGrant/award (A): 1,750 @ $0 · Grant/award (A): 7,800 (derivative) @ $0EDGAR
2021-06-214McDonnell Peter J — DirectorGrant/award (A): 1,750 @ $0 · Grant/award (A): 7,800 (derivative) @ $0EDGAR
2021-06-214Croarkin Richard — DirectorGrant/award (A): 1,750 @ $0 · Grant/award (A): 7,800 (derivative) @ $0EDGAR
2021-06-214MCGRAW BENJAMIN F III — DirectorGrant/award (A): 1,750 @ $0 · Grant/award (A): 7,800 (derivative) @ $0EDGAR
2021-06-214GRYSKA DAVID W — DirectorGrant/award (A): 1,750 @ $0 · Grant/award (A): 7,800 (derivative) @ $0EDGAR
2021-02-254MITRO THOMAS A — President and COOTax withholding (F): 763 @ $15.66EDGAR
2021-02-254ANIDO VICENTE JR — Chief Executive Officer, DirectorTax withholding (F): 1,700 @ $15.66EDGAR

Recent 8-K events — AERIE PHARMACEUTICALS INC

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2022-11-218-K1.01 — Entry into a Material Definitive Agreement
1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2022-11-188-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2022-11-078-K8.01 — Other EventsEDGAR
2022-11-038-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-09-138-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-08-238-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-08-238-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2022-08-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2022-08-018-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-06-138-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=AERI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs